Companion Diagnostics: From Biomarker Identification to Market Entry
Conference - New York City, United States
Biomarker-based companion diagnostics (CDx), designed to identify treatment responsive patients, lie at the heart of the emerging personalized, precision medicine movement. This 2-day conference will discuss research, financial, and regulatory strategies to facilitate CDx development and integration. Presentations will analyze diverse therapeutic target areas beyond cancer such as inflammatory, infectious, cardiovascular, metabolic, and neurodegenerative diseases; evaluate emerging applications of technologies such as epigenetics, bioinformatics, and nanotechnology; illustrate successes and failures via case studies; recognize regulatory hurdles; and formulate solutions to better improve public health with CDx and personalized medicine.
Organization: The New York Aacdemy of Sciences
(Courtesy of The New York Academy of Sciences, New York City, United States, via som.com)
Companion Diagnostics: From Biomarker Identification to Market Entry
28–29 April 2014
The New York Academy of Sciences Conference Center,
New York City, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.